Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-19

Clinical Trial Update: 0,9% NaCl Effect on Kidney Function and Glycocalyx in Patients Operated on for Primary Hiparthrosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating whether 0.9% saline affects kidney function and the glycocalyx in patients undergoing surgery for primary hip arthrosis. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium chloride 0.9% (Normal saline) (Sodium chloride)

Snippet

Sponsor: Regional Hospital Holstebro | Conditions: Nephrotoxicity | Phase 4 | Status: UNKNOWN